Your browser doesn't support javascript.
loading
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin.
Teng, Xiaozhong; Hayashida, Tetsu; Murata, Takeshi; Nagayama, Aiko; Seki, Tomoko; Takahashi, Maiko; Kitagawa, Yuko.
Affiliation
  • Teng X; Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan.
  • Hayashida T; Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan. tetsu@z7.keio.jp.
  • Murata T; Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan.
  • Nagayama A; Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan.
  • Seki T; Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan.
  • Takahashi M; Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan.
  • Kitagawa Y; Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku, Tokyo, 160-8582, Japan.
Breast Cancer ; 28(4): 884-895, 2021 Jul.
Article in En | MEDLINE | ID: mdl-33616862

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / NF-kappa B / Drug Resistance, Neoplasm / Tubulin Modulators / Furans / Ketones Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / NF-kappa B / Drug Resistance, Neoplasm / Tubulin Modulators / Furans / Ketones Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Japón